| Age (years) | 67.1 ± 9.3 |
| Male gender | 17 |
| BMI (kg/m2) | 26.0 ± 4.6 |
| Hypertension | 14 |
| Type 2 diabetes | 2 |
| Smoking status | |
| Current | 4 |
| Previous | 10 |
| Never | 6 |
| Cholesterol (mmol/l) | |
| Total | 4.5 ± 0.8 |
| LDL | 2.1 ± 1.0 |
| HDL | 1.7 ± 0.4 |
| HbA1c (mmol/mol) | 37.4 ± 6.4 |
| NIHSS (score range 0–42) | 0.2 ± 0.4 |
| mRS (score range 0–6) | 0.7 ± 0.5 |
| MOCA (score range 0–30) | 26.7 ± 2.9 |
| Index stroke localization | |
| Internal capsule/lentiform | 4 |
| Internal border zone | 3 |
| Centrum semiovale | 4 |
| Thalamus/hypothalamus | 6 |
| Brainstem, incl. pons | 4 |
| Anterior border zone | 0 |
| Posterior border zone | 0 |
| Age (years) | 67.1 ± 9.3 |
| Male gender | 17 |
| BMI (kg/m2) | 26.0 ± 4.6 |
| Hypertension | 14 |
| Type 2 diabetes | 2 |
| Smoking status | |
| Current | 4 |
| Previous | 10 |
| Never | 6 |
| Cholesterol (mmol/l) | |
| Total | 4.5 ± 0.8 |
| LDL | 2.1 ± 1.0 |
| HDL | 1.7 ± 0.4 |
| HbA1c (mmol/mol) | 37.4 ± 6.4 |
| NIHSS (score range 0–42) | 0.2 ± 0.4 |
| mRS (score range 0–6) | 0.7 ± 0.5 |
| MOCA (score range 0–30) | 26.7 ± 2.9 |
| Index stroke localization | |
| Internal capsule/lentiform | 4 |
| Internal border zone | 3 |
| Centrum semiovale | 4 |
| Thalamus/hypothalamus | 6 |
| Brainstem, incl. pons | 4 |
| Anterior border zone | 0 |
| Posterior border zone | 0 |
Results shown as mean ± SD or an amount (n). Index stroke localization was determined from an MRI scan (index scan) upon patient admittance to the stroke department.
BMI: body mass index; HbA1c: haemoglobin A1c; HDL: high-density lipoprotein; LDL: low-density lipoprotein; MOCA: Montreal Cognitive Assessment; mRS: modified Rankin Scale; NIHSS: National Institutes of Health Stroke Scale.
| Age (years) | 67.1 ± 9.3 |
| Male gender | 17 |
| BMI (kg/m2) | 26.0 ± 4.6 |
| Hypertension | 14 |
| Type 2 diabetes | 2 |
| Smoking status | |
| Current | 4 |
| Previous | 10 |
| Never | 6 |
| Cholesterol (mmol/l) | |
| Total | 4.5 ± 0.8 |
| LDL | 2.1 ± 1.0 |
| HDL | 1.7 ± 0.4 |
| HbA1c (mmol/mol) | 37.4 ± 6.4 |
| NIHSS (score range 0–42) | 0.2 ± 0.4 |
| mRS (score range 0–6) | 0.7 ± 0.5 |
| MOCA (score range 0–30) | 26.7 ± 2.9 |
| Index stroke localization | |
| Internal capsule/lentiform | 4 |
| Internal border zone | 3 |
| Centrum semiovale | 4 |
| Thalamus/hypothalamus | 6 |
| Brainstem, incl. pons | 4 |
| Anterior border zone | 0 |
| Posterior border zone | 0 |
| Age (years) | 67.1 ± 9.3 |
| Male gender | 17 |
| BMI (kg/m2) | 26.0 ± 4.6 |
| Hypertension | 14 |
| Type 2 diabetes | 2 |
| Smoking status | |
| Current | 4 |
| Previous | 10 |
| Never | 6 |
| Cholesterol (mmol/l) | |
| Total | 4.5 ± 0.8 |
| LDL | 2.1 ± 1.0 |
| HDL | 1.7 ± 0.4 |
| HbA1c (mmol/mol) | 37.4 ± 6.4 |
| NIHSS (score range 0–42) | 0.2 ± 0.4 |
| mRS (score range 0–6) | 0.7 ± 0.5 |
| MOCA (score range 0–30) | 26.7 ± 2.9 |
| Index stroke localization | |
| Internal capsule/lentiform | 4 |
| Internal border zone | 3 |
| Centrum semiovale | 4 |
| Thalamus/hypothalamus | 6 |
| Brainstem, incl. pons | 4 |
| Anterior border zone | 0 |
| Posterior border zone | 0 |
Results shown as mean ± SD or an amount (n). Index stroke localization was determined from an MRI scan (index scan) upon patient admittance to the stroke department.
BMI: body mass index; HbA1c: haemoglobin A1c; HDL: high-density lipoprotein; LDL: low-density lipoprotein; MOCA: Montreal Cognitive Assessment; mRS: modified Rankin Scale; NIHSS: National Institutes of Health Stroke Scale.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
